phosphatidylcholines has been researched along with Metabolic Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| D'Amore, S; Griffin, JL; Hall, Z; Herrera-Marcos, LV; Jenkins, B; Kay, R; Koulman, A; Mocciaro, G; Moschetta, A; Murgia, A; Murray, A; Neun, S; Palasciano, G; Palma-Duran, SA; Reimann, F; Sabbà, C; Sowton, AP; Suppressa, P; Vacca, M | 1 |
| Gong, LL; Han, FF; Liu, H; Liu, LH; Lv, YL; Xuan, LL; Yang, S; Zhang, W | 1 |
| Burda, M; Macášek, J; Staňková, B; Tvrzická, E; Vecka, M; Žák, A; Zeman, M | 1 |
| Gloor, GB; Joris, BR | 1 |
| Almasy, L; Barlow, CK; Bellis, C; Blangero, J; Comuzzie, AG; Curran, JE; Dyer, TD; Johnson, MP; Jowett, JB; Kulkarni, H; Mahaney, MC; Mamtani, M; Meikle, PJ; Rainwater, DL; Weir, JM | 1 |
| Schroën, Y; van der Greef, J; van Wietmarschen, HA; Wang, M | 1 |
| Burda, M; Staňková, B; Tvrzická, E; Vecka, M; Žák, A; Zeman, M | 1 |
| Daniluk, J; Kandefer-Szerszeń, M; Szuster-Ciesielska, A; Słabczyńska, O; Zwolak, A | 1 |
| Ito, J; Kato, S; Kimura, F; Miyazawa, T; Nakagawa, K | 1 |
| Cash, JG; Hui, DY | 1 |
| Berge, RK; Bhurruth-Alcor, Y; Bohov, P; Dyrøy, E; Guisado, C; Jorgensen, MR; Kostarelos, K; Miller, AD; Müller, M; Røst, T; Skorve, J | 1 |
| Jáchymová, M; Jirák, R; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M | 1 |
| Carreón-Torres, E; Cruz-Robles, D; García-Sánchez, C; Juárez-Meavepeña, M; López-Osorio, C; Monter-Garrido, M; Pérez-Méndez, O; Toledo-Ibelles, P; Torres-Tamayo, M; Vargas-Alarcón, G | 1 |
| Fève, B; Kuhn, E; Lombès, M | 1 |
2 review(s) available for phosphatidylcholines and Metabolic Syndrome
| Article | Year |
|---|---|
Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carnitine; Choline; Energy Metabolism; Fatty Acids, Volatile; Gastrointestinal Microbiome; Genomics; High-Throughput Nucleotide Sequencing; Humans; Lipid Metabolism; Metabolic Syndrome; Methylamines; Phosphatidylcholines; RNA, Ribosomal, 16S; T-Lymphocytes, Helper-Inducer; Triglycerides | 2019 |
[New pathophysiological mechanisms of metabolic syndrome: implication of orphan nuclear receptors?].
Topics: Animals; Fatty Liver; Glucocorticoids; Humans; Hypoglycemic Agents; Liver X Receptors; Metabolic Syndrome; Mice; Mice, Knockout; Orphan Nuclear Receptors; Phosphatidylcholines; Receptors, Cytoplasmic and Nuclear | 2012 |
1 trial(s) available for phosphatidylcholines and Metabolic Syndrome
| Article | Year |
|---|---|
Evaluation of symptom, clinical chemistry and metabolomics profiles during Rehmannia six formula (R6) treatment: an integrated and personalized data analysis approach.
Topics: Adult; Blood Pressure; Cholesterol; Drugs, Chinese Herbal; Female; Fever; Humans; Male; Metabolic Syndrome; Metabolomics; Middle Aged; Phosphatidylcholines; Principal Component Analysis; Qi; Rehmannia; Sweating; Yin Deficiency | 2013 |
11 other study(ies) available for phosphatidylcholines and Metabolic Syndrome
| Article | Year |
|---|---|
Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome.
Topics: Cholesterol; Cholesterol, HDL; Humans; Insulin Resistance; Lipidomics; Lipoproteins; Metabolic Syndrome; Obesity; Obesity, Abdominal; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines | 2022 |
Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Topics: Adult; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Lipid Metabolism; Lipidomics; Male; Metabolic Syndrome; Middle Aged; Phosphatidylcholines; Risk Assessment; Tandem Mass Spectrometry | 2020 |
Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.
Topics: Adiposity; Adult; Anthropometry; Case-Control Studies; Chromatography, Liquid; Cross-Sectional Studies; Fatty Acids; Female; Humans; Insulin Resistance; Linear Models; Lipids; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Phosphatidylcholines; Pilot Projects; Regression Analysis; Stearoyl-CoA Desaturase; Waist Circumference; Waist-Hip Ratio | 2017 |
Variability in associations of phosphatidylcholine molecular species with metabolic syndrome in Mexican-American families.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Humans; Male; Mass Spectrometry; Metabolic Syndrome; Mexican Americans; Middle Aged; Phosphatidylcholines; Risk Factors; United States | 2013 |
Fatty acid composition indicates two types of metabolic syndrome independent of clinical and laboratory parameters.
Topics: Aged; Cluster Analysis; Fatty Acids; Feeding Behavior; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Phosphatidylcholines | 2014 |
Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.
Topics: Cytokines; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Ketoglutaric Acids; Leukocytes; Lipopolysaccharides; Male; Metabolic Syndrome; Metformin; Middle Aged; Monocytes; Non-alcoholic Fatty Liver Disease; Obesity; Phosphatidylcholines; Toll-Like Receptor 4 | 2015 |
The combination of maternal and offspring high-fat diets causes marked oxidative stress and development of metabolic syndrome in mouse offspring.
Topics: Animals; Diet, High-Fat; Female; Fetal Development; Gene Expression; Glutathione Peroxidase; Lipids; Liver; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Overnutrition; Oxidative Stress; Phosphatidylcholines; Phospholipid Hydroperoxide Glutathione Peroxidase; Pregnancy; Prenatal Exposure Delayed Effects | 2016 |
Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Cardiovascular Diseases; Disease Models, Animal; Gene Expression Regulation; Glucose Tolerance Test; Group IB Phospholipases A2; Hepatocytes; Humans; Hyperglycemia; Lipid Metabolism; Liver; Lysophosphatidylcholines; Male; Metabolic Syndrome; Metabolome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphatidylcholines; Postprandial Period; Triglycerides | 2016 |
Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.
Topics: Animals; Glycerides; Glycerol; Male; Metabolic Syndrome; Peroxisome Proliferator-Activated Receptors; Phosphatidylcholines; Rats; Rats, Wistar; Sulfides | 2009 |
Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Blood Glucose; Chromatography, Gas; Coenzyme A Ligases; Depression; Fatty Acids; Female; Humans; Insulin; Male; Metabolic Syndrome; Phosphatidylcholines; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Radioimmunoassay | 2009 |
Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome.
Topics: Case-Control Studies; Child; Cholesterol; Electrophoresis, Polyacrylamide Gel; Enzymes; Female; Humans; Lipoproteins, HDL; Male; Metabolic Syndrome; Phosphatidylcholines; Surface Properties; Triglycerides | 2011 |